These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12163387)

  • 1. Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.
    Toyooka KO; Toyooka S; Maitra A; Feng Q; Kiviat NC; Smith A; Minna JD; Ashfaq R; Gazdar AF
    Am J Pathol; 2002 Aug; 161(2):629-34. PubMed ID: 12163387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
    J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
    Lombaerts M; Middeldorp JW; van der Weide E; Philippo K; van Wezel T; Smit VT; Cornelisse CJ; Cleton-Jansen AM
    Biochem Biophys Res Commun; 2004 Jun; 319(2):697-704. PubMed ID: 15178462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
    Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
    Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility].
    Aristizábal-Pachón AF; Takahashi CS
    Biomedica; 2016 Dec; 36(4):593-602. PubMed ID: 27992986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
    Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
    Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sun exposure related methylation in malignant and non-malignant skin lesions.
    Sathyanarayana UG; Moore AY; Li L; Padar A; Majmudar K; Stastny V; Makarla P; Suzuki M; Minna JD; Feng Z; Gazdar AF
    Cancer Lett; 2007 Jan; 245(1-2):112-20. PubMed ID: 16494996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
    Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
    Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
    J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman.
    Hu XC; Loo WT; Chow LW
    Life Sci; 2002 Aug; 71(12):1397-404. PubMed ID: 12127160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.